a.a.	Amino acid
Aβ	Amyloid-β peptide
AD	Alzheimer’s Disease
AGD	Argyrophilic grain disease
ALS	Amyotrophic lateral sclerosis
APP	Amyloid precursor protein
BBB	Blood–brain barrier
CAA	Cerebral amyloid angiopathy
CBD	Corticobasal degeneration
CPE	Carboxypeptidase E
CNS	Central nervous system
Cryo-EM	Cryo-electron microscopy
CSF	Cerebrospinal fluid
CTR	Calcitonin receptor
DLB	Dementia with Lewi bodies
EPR	Electron paramagnetic resonance spectroscopy
FRET	Förster resonance energy transfer
FTLD	Frontotemporal lobar degeneration
FTLD-TDP	TDP-43 positive frontotemporal lobar degeneration
GCI	Glial cytoplasmic inclusions
GRD	Glycine-rich domain
GSK	Glycogen synthase kinase
HEK293	Human embryonic kidney 293 cells
IAPP	Islet amyloid polypeptide
IDE	Insulin-degrading enzyme
LB	Lewy bodies
LBDs	Lewy body diseases
LCOs	Luminescent conjugated oligothiophenes
LN	Lewy neurites
MSA	Multiply system atrophy
NAC	Non-amyloid component
NES	Nuclear export signal
NFTs	Neurofibrillary tangles
NLS	Nuclear localization signal
NMR	Nuclear Magnetic Resonance spectroscopy
NTs	Neuropil threads
PAGE	Polyacrylamide gel electrophoresis
PART	Primary age-related tauopathy
PAM	Peptidylglycine alpha-amidating monooxygenase
PD	Parkinson’s disease
PDD	Parkinson’s disease dementia
PiD	Pick’s Disease
PMCA	Protein Misfolding Cyclic Amplification technique
PK	Proteinase K
PrP	Prion protein
PSP	Progressive supranuclear palsy
PTMs	Post-translational modifications
RAMP3	Receptor activity modifying protein 3
RBD	RNA-binding domain
RNP	Ribonuclear protein
α-Syn	α-Synuclein
SDS	Sodium dodecyl sulphate
SUMO	Small Ubiquitin-like Modifier
T1DM	Type I diabetes mellitus
T2DM	Type II diabetes mellitus
TDP-43	Transactive response DNA-binding protein of 43 kDa
TMEM106B	Transmembrane protein 106B